Loading...
XHKG
0719
Market cap1.03bUSD
Jul 10, Last price  
5.80HKD
1D
-2.19%
1Q
-9.23%
Jan 2017
43.92%
Name

Shandong Xinhua Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XHKG:0719 chart
P/E
8.69
P/S
0.29
EPS
0.58
Div Yield, %
5.08%
Shrs. gr., 5y
2.15%
Rev. gr., 5y
7.80%
Revenues
8.74b
+3.26%
1,667,251,8731,886,978,9512,077,753,0002,321,927,2132,614,233,6342,937,528,0552,971,519,6203,391,228,6563,589,749,7703,597,033,2094,014,963,0644,515,716,7835,244,643,5615,606,020,8626,005,586,6436,560,077,5857,502,987,1018,100,844,7068,466,309,8028,742,524,967
Net income
290m
-38.32%
22,705,55732,723,03430,064,000102,244,34697,256,60276,023,66523,663,58139,153,12650,725,31583,062,261122,271,553209,591,912255,314,459299,966,268324,859,563348,548,501411,063,061496,512,206470,023,747289,888,855
CFO
534m
+45.19%
133,303,506120,591,043103,479344,796,000173,000,00097,083,00037,818,00092,637,000346,342,000348,636,176439,348,332389,971,809344,609,119348,271,406420,186,808259,116,960758,240,601265,278,895367,610,448533,728,707
Dividend
Sep 04, 20240.027289 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. It also provides ibuprofen bulk pharmaceutical products; and prepared Chinese herbal medicine for decoction, traditional Chinese medicine, chemical bulk drugs, chemical preparations, chemical raw materials, antibiotics, biochemical medicines, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc. In addition, the company offers raw materials and intermediates; internet data services, internet sales, and internet information services for pharmaceuticals and medical devices; veterinary drugs and fodders; bulk pharmaceutical and intermediates; steroid system apis and intermediates; and chemical raw materials. Further, the company produces and sells chemical products; exports and imports goods and technologies; and designs medical projects. Additionally, it engages in the property management, nonresidential real estate leasing, and housing leasing activities; certification and import and export business; electrical equipment engineering; installation and testing of chemical equipment; and manufacture of mechanical and electrical equipment, nonstandard equipment, as well as production and hardware and electrical equipment, and electrical installations equipment and manufacture; and sale of controller switching equipment. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.
IPO date
Dec 31, 1996
Employees
6,839
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT